Patients with low MLKL levels in pancreatic adenocarcinoma [26, 27], colon cancer [28], gastric cancer [29], cervical cancer [30, 31], and ovarian cancer [32] apparently have worsened overall survival. Here, MLKL is linked to malignant colon neoplasm.